🇺🇸 Norepinephrine infusion in United States

56 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Creatinine Increased — 10 reports (17.86%)
  2. Hypotension — 8 reports (14.29%)
  3. Alanine Aminotransferase Increased — 7 reports (12.5%)
  4. Aspartate Aminotransferase Increased — 6 reports (10.71%)
  5. Acute Kidney Injury — 5 reports (8.93%)
  6. Shock — 5 reports (8.93%)
  7. Hypoxia — 4 reports (7.14%)
  8. International Normalised Ratio Increased — 4 reports (7.14%)
  9. Septic Shock — 4 reports (7.14%)
  10. Acute Respiratory Distress Syndrome — 3 reports (5.36%)

Source database →

Norepinephrine infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Norepinephrine infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Norepinephrine infusion in United States?

Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.